April 17, 2020 Optimism for a flattening COVID-19 curve in the U.S. and high hopes for Gilead’s experimental drug treatment for COVID-19 pushed the S&P 500 to a 3.04% weekly gain. The move comes on the heals of last week’s 12.10% rise, the index’s best one-week performance since 1974. The positive developments sparked investor optimism…
Read More
April 3, 2020 After rallying as much as 18% from its March 23rd low, the S&P 500 settled into a range this week. Drug industry breakthroughs, a stronger federal government response to tackle the COVID-19 outbreak, and news of a potential deal between Saudi Arabia and Russia to cut oil production helped to support stocks…
Read More
March 27, 2020 Encouraged by the government passing a $2 trillion lifeline package and the Federal Reserve, who has vowed that it will not run out of ammunition in its support for financial markets, investors sent the S&P 500 surging by 20%+ over a 3-day period. The government’s massive stimulus package is unprecedented in its…
Read More